id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-001765-7wv4cb37	Matassov, Demetrius	Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus	2015-06-24		.txt	text/plain	4876	184	41	Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations Serologic cross-reactivity of human IgM and IgG antibodies to five species of Ebola virus Fruit bats as reservoirs of Ebola virus Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species Ebola-a growing threat? Case fatality rate for Ebola virus disease in West Africa Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection Progress in filovirus vaccine development: evaluating the potential for clinical use Single immunization with a monovalent vesicular stomatitis virus-based vaccine protects nonhuman primates against heterologous challenge with Bundibugyo ebolavirus Recombinant vesicular stomatitis virusbased vaccines against Ebola and Marburg virus infections The epizootiology of the vesicular stomatitis viruses: a reappraisal Vesicular stomatitis virus, Indiana serotype: multiplication in and transmission by experimentally infected phlebotomine sandflies (Lutzomyia trapidoi) Vesicular stomatitis virus (Indiana serotype): transovarial transmission by phlebotomine sandflies Clinical and serological response to laboratory-acquired human infection by Indiana type vesicular stomatitis virus (VSV) Natural infection of humans, animals, and phlebotomine sand flies with the Alagoas serotype of vesicular stomatitis virus in Colombia Recombinant vesicular stomatitis viruses from DNA Replicationcompetent or attenuated, nonpropagating vesicular stomatitis viruses expressing respiratory syncytial virus (RSV) antigens protect mice against RSV challenge Long-term protection from SARS coronavirus infection conferred by a single immunization with an attenuated VSV-based vaccine Attenuated vesicular stomatitis viruses as vaccine vectors An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants Sequential transcription of the genes of vesicular stomatitis virus Order of transcription of genes of vesicular stomatitis virus Phenotypic consequences of rearranging the P, M, and G genes of vesicular stomatitis virus Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates Attenuation of recombinant vesicular stomatitis virus HIV-1 vaccine vectors by gene translocations and G gene truncation reduces neurovirulence and enhances immunogenicity in mice In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation Synergistic attenuation of vesicular stomatitis virus by combination of specific G gene truncations and N gene translocations Guide for the care and use of laboratory animals An efficient helper-virus-free method for rescue of recombinant paramyxoviruses and rhadoviruses from a cell line suitable for vaccine development A simple method of estimating fifty percent endpoints Pathogenesis of experimental Ebola virus infection in guinea pigs Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses Enzyme-linked immunosorbent assay for detection of filovirus species-specific antibodies Vesicular stomatitis virus-based Ebola vaccines with improved cross-protective efficacy Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses Structure-function analysis of the soluble glycoprotein, sGP, of Ebola virus Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis Ebola virus-like particles protect from lethal Ebola virus infection Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of Ebola virus GP DNA vaccines Ebola virus entry requires the cholesterol transporter Niemann-Pick C1 Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors Natural killer cells in antiviral defense: function and regulation by innate cytokines Financial support.	cache/cord-001765-7wv4cb37.txt	txt/cord-001765-7wv4cb37.txt
